07/16/2025
6:02 PM | BlackRock, Inc. (Filed by)
Ventyx Biosciences (Subject)
| Form SCHEDULE 13G/A | |
06/17/2025
7:00 AM | Ventyx Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2025
1:26 PM | Ventyx Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2025
2:10 PM | HULME ALLISON (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
2:11 PM | Cadoret-Manier Onaiza (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
2:04 PM | Gujrathi Sheila (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
2:06 PM | Ventyx Biosciences (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2025
2:08 PM | Subramaniam Somu (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2025
6:01 PM | Affinity Asset Advisors, LLC (Filed by)
Ventyx Biosciences (Subject)
| Form SCHEDULE 13G | |
05/16/2025
5:41 PM | Gonzales Roy (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/16/2025
5:40 PM | Forman Mark S (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for VTYX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Ventyx Biosciences and its competitors with MarketBeat's FREE daily newsletter. |
05/15/2025
4:29 PM | CITADEL ADVISORS LLC (Filed by)
Ventyx Biosciences (Subject)
| Form SCHEDULE 13G/A | |
05/15/2025
12:10 PM | BANK OF AMERICA CORP /DE/ (Filed by)
Ventyx Biosciences (Subject)
| Form SCHEDULE 13G/A | |
04/23/2025
3:30 PM | Ventyx Biosciences (Filer)
| Form DEFA14A | |
04/23/2025
3:45 PM | Ventyx Biosciences (Filer)
| Form ARS | |
04/23/2025
3:15 PM | Ventyx Biosciences (Filer)
| Form DEF 14A | |
04/08/2025
2:14 PM | Sio Capital Management, LLC (Filed by)
Ventyx Biosciences (Subject)
| Form SCHEDULE 13G/A | |
04/03/2025
3:21 PM | Nuss John (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
8:40 PM | NSV Partners III LP (Filed by)
Ventyx Biosciences (Subject)
| Form SCHEDULE 13D/A | |
04/01/2025
3:35 PM | Nuss John (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
3:36 PM | Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2025
3:32 PM | Subramaniam Somu (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2025
4:17 PM | Subramaniam Somu (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2025
7:15 AM | Ventyx Biosciences (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025
4:21 PM | Ventyx Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/27/2025
3:11 PM | Ventyx Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2025
5:09 PM | BANK OF AMERICA CORP /DE/ (Filed by)
Ventyx Biosciences (Subject)
| Form SCHEDULE 13G | |
02/13/2025
7:59 AM | Flynn James E (Filed by)
Ventyx Biosciences (Subject)
| Form SCHEDULE 13G/A | |
02/10/2025
11:59 AM | Sio Capital Management, LLC (Filed by)
Ventyx Biosciences (Subject)
| Form SCHEDULE 13G | |
01/29/2025
5:58 PM | Point72 Asset Management, L.P. (Filed by)
Ventyx Biosciences (Subject)
| Form SCHEDULE 13G | |
01/14/2025
8:15 AM | Ventyx Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/03/2025
5:50 PM | Forman Mark S (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:52 PM | Gonzales Roy (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:53 PM | Moore Matthew Richard (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:54 PM | Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/03/2025
5:57 PM | Nuss John (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/30/2024
4:33 PM | Nuss John (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/27/2024
3:46 PM | Nuss John (Reporting)
Ventyx Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2024
7:05 PM | Gujrathi Sheila (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
5:49 PM | Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/19/2024
5:50 PM | Nuss John (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Coin That Could Define Trump’s Crypto Presidency (Ad) When Trump returned to office, one of his first moves was to tap PayPal’s former COO, David Sacks, as a top advisor on crypto and AI. That alone signaled a shift. But insiders close to D.C. aren’t just talking crypto policy—they’re quietly buying something most retail investors have missed.
While the crowd chases Bitcoin to $150,000, Weiss Ratings expert Juan Villaverde believes a different coin—already backed by giants like Google, Visa, and PayPal—could soon become crypto’s “Third Giant.” Discover the coin that could define Trump’s crypto presidency. |
12/19/2024
5:48 PM | Nuss John (Reporting)
Ventyx Biosciences (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2024
4:21 PM | Nuss John (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/25/2024
8:07 PM | Mohan Raju (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2024
11:15 PM | Ventyx Biosciences (Filer)
| Form EFFECT | |
11/15/2024
3:59 PM | Ventyx Biosciences (Filer)
| Form 424B3 | |
11/14/2024
6:54 PM | Point72 Asset Management, L.P. (Filed by)
Ventyx Biosciences (Subject)
| Form SC 13G/A | |
11/14/2024
2:06 PM | Cormorant Asset Management, LP (Filed by)
Ventyx Biosciences (Subject)
| Form SC 13G/A | |
11/14/2024
7:57 AM | Flynn James E (Filed by)
Ventyx Biosciences (Subject)
| Form SC 13G/A | |
11/07/2024
3:58 PM | Ventyx Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
4:13 PM | Ventyx Biosciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
09/30/2024
3:40 PM | Ventyx Biosciences (Filer)
| Form D
Notice of Exempt Offering of Securities | |
09/23/2024
7:18 AM | Ventyx Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/09/2024
3:47 PM | Gonzales Roy (Reporting)
Ventyx Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/30/2024
7:15 AM | Ventyx Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:48 PM | Forman Mark S (Reporting)
Ventyx Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/13/2024
3:35 PM | Forman Mark S (Reporting)
Ventyx Biosciences (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
MarketBeat All Access